Volume 118, Issue 3 , Pages 666-673, September 2006
Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice
Background
New preventive strategies against the development of allergic diseases focus on potentially immunomodulatory components, such as bacterial LPSs. Optimal time frames for initiating immunomodulation to receive a sufficient effect against allergen sensitization are still unclear.
Objective
Using a mouse model, we investigated the influence of prenatal LPS exposure on later allergen-mediated sensitization and airway inflammation in the offspring.
Methods
Pregnant BALB/c mice were repeatedly exposed to aerosolized LPS (LPS Escherichia coli; 3× per week, day 7 of gestation time up to delivery). Some of the offspring were further exposed to aerosolized LPS before allergen sensitization with ovalbumin (OVA; administered intraperitoneally day 28 up to day 42) and OVA airway challenges (days 56-58). Positive control animals were placebo exposed to PBS instead of LPS, and negative control animals were first placebo exposed and later placebo sensitized with PBS instead of OVA.
Results
Compared with positive control animals, prenatal LPS exposure suppressed (1) allergen-specific sensitization (IgE production), (2) eosinophilic airway inflammation (reduced numbers of eosinophils in bronchoalveolar lavage fluids), and (3) in vivo airway reactivity in response to methacholine. These effects occurred only when prenatal was combined with further postnatal LPS exposure. Suppression of allergen-mediated inflammatory responses was associated with increased Toll-like receptor and T-bet expression by lung tissues and a shift toward predominantly TH1 immune responses in spleen cells cultured with OVA in vitro.
Conclusion
Prenatal initiated and postnatal sustained LPS exposure increased endotoxin susceptibility and prevented later allergen sensitization in offspring through inhibition of TH2 immune responses.
Clinical implications
Immunomodulation with bacterial compounds during gestation time might be an effective mode for first-step primary prevention against allergic diseases.
Key words: Asthma, cytokines, lipopolysaccharides, mice, ovalbumin
Abbreviations used: AI, Airway inflammation, AR, Airway reactivity, CD62L, L-selectin, ConA, Concanavalin A, DC, Dendritic cell, LBP, LPS-binding protein, MCh, Methacholine, MNC, Mononuclear cell, OVA, Ovalbumin, Penh, Enhanced pause, sCD14, Soluble CD14, TLR, Toll-like receptor, Treg cell, T regulatory cell
E. Hamelmann is supported by the EC (GA2LEN/FP6/CT-2004-506378) and the German Ministry of Health (BMBF 01 ZZ 01042000/Inflammation and Immune Reactions/NBL-3). A. Avagyan is a fellow of Sonnenfeldstiftung. R. Lauener is supported by the Swiss National Foundation (project No. 32-100324) and by the Kühne-Foundation, Switzerland.Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(06)01197-3
doi:10.1016/j.jaci.2006.05.022
© 2006 American Academy of Allergy, Asthma and Immunology. Published by Elsevier Inc. All rights reserved.
Volume 118, Issue 3 , Pages 666-673, September 2006
